Strategic partnerships CancerIQ is actively expanding its Epic integrations and forming partnerships with AI and risk assessment providers, signaling a readiness to integrate with broader health system workflows and expand adoption through ecosystem collaboration.

Expansion momentum Recent funding and new strategic partners, along with a growing footprint across 60+ health systems and 275 clinic locations, indicate strong growth velocity and multiple upsell opportunities within existing clients and adjacent care settings.

Risk assessment focus Introduction of geneType cancer risk assessment and polygenic risk scoring expands the platform’s capability to deliver proactive, risk-based screening, enabling selling points around preventive care programs and value-based outcomes.

Population reach Launch of CancerIQ Reach and population-based outreach campaigns provides a channel for enhancing patient acquisition initiatives, creating cross-sell opportunities with imaging and oncology teams seeking higher-risk patient engagement.

Data-driven integrations A tech stack centered on analytics, cloud infrastructure, and CRM tooling (Looker, Tableau, Google Cloud, iCIMS, HubSpot) suggests strong potential to upsell advanced analytics, reporting, and automation enhancements to optimize clinician workflows and outcomes.